Structure |
Chemical Name |
CAS |
MF |
 |
Pazopanib iMpurity |
|
|
![Acetic acid, 2-[2-[2-[4-[(4- chlorophenyl)phenylMethyl]-1-piperazinyl]ethoxy]ethoxy]-](/CAS/20150408/GIF/682323-77-9.gif) |
Acetic acid, 2-[2-[2-[4-[(4- chlorophenyl)phenylMethyl]-1-piperazinyl]ethoxy]ethoxy]- |
682323-77-9 |
C23H29ClN2O4 |
 |
edaravone iMpurity |
|
|
 |
(2R,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
C24H25FO5S |
 |
5-(4-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
 |
Ganciclovir EP Impurity H |
84222-50-4 |
C9H13N5O4 |
![2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine](/CAS/20150408/GIF/97151-10-5.gif) |
2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine |
97151-10-5 |
C24H25NO |
![[S-(R*,R*)]-3,3'-Dithiobis[2-methylpropanoic acid]](/CAS/20150408/GIF/65134-74-9.gif) |
[S-(R*,R*)]-3,3'-Dithiobis[2-methylpropanoic acid] |
65134-74-9 |
C8H14O4S2 |
![(E)-1-(4-(2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)ethanone](/CAS/20150408/GIF/935272-10-9.gif) |
(E)-1-(4-(2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)ethanone |
935272-10-9 |
C18H20N4OS |
 |
2-(thiophen-3-yl)ethyl 4-methylbenzenesulfonate |
40412-09-7 |
C13H14O3S2 |
 |
4-Nitrophenyl 5-chlorothiophene-2-carboxylate |
1450877-56-1 |
C11H6ClNO4S |
 |
Olaparib iMpurity B |
|
|
 |
Posaconazole iMpurity 6 |
2185472-85-7 |
C30H35N5O3 |
 |
Everolimus Isomer C |
|
|
 |
3-Deschloro-4-Desfluoro-4-Chloro-3-Fluorogefitinib |
1603814-04-5 |
C22H24ClFN4O3 |
 |
Brivaracetam (Racemate) |
357335-87-6 |
C11H20N2O2 |
 |
Donepezil Impurity 2 |
36517-91-6 |
C11H10O4 |
 |
Fesoterodine Related Impurity 2 |
1254942-29-4 |
C30H39NO6 |
 |
Prasugrel Impurity 13 HCl |
1618108-01-2 |
C18H19ClFNOS |
 |
Ticagrelor Related Compound 5 |
1414348-35-8 |
C9H9F2N |
 |
Vortioxetine Impurity 2 |
1293489-69-6 |
C17H20N2S |
 |
(S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid |
1151893-81-0 |
C24H21Cl2N3O7S2 |
 |
シラスタチン アンモニウム塩 |
877674-82-3 |
C16H29N3O5S |
 |
ACETIC ACID 2-METHOXY-4-(5-OXO-2-PHENYL-OXAZOL-4-YLIDENEMETHYL)-PHENYL ESTER |
18692-68-7 |
C19H15NO5 |
![1,4-di(benzo[b]thiophen-4-yl)piperazine](/CAS/20180703/GIF/1420987-86-5.gif) |
1,4-di(benzo[b]thiophen-4-yl)piperazine |
1420987-86-5 |
C20H18N2S2 |
![(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180703/GIF/1012341-52-4.gif) |
(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-52-4 |
C23H29NO4 |
 |
DONEPEZIL IMP |
923571-16-8 |
C24H22NO4.Cl |
 |
Parecoxib Impurity N |
|
|
![5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester](/CAS/20180703/GIF/87475-54-5.gif) |
5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
87475-54-5 |
C18H25Cl2N3O2 |
 |
Topiroxostat Impurity Ⅱ-3 |
|
|
 |
Ivabradine related compound 9 |
85175-49-1 |
C12H13NO4 |
 |
blonanserin impurity O |
|
|
 |
Butyphthalide impurity 42 |
952412-79-2 |
C10H12O3 |
 |
Butyphthalide impurity 48 |
|
|
 |
Dapoxetine impurity 20 |
|
|
 |
2-((4-(カルボキシメチル)フェノキシ)メチル)安息香酸 |
55453-89-9 |
C16H14O5 |
 |
Ipragliflozin Impurity 5 |
|
|
 |
Ibrutinib Impurity 18 |
1881246-01-0 |
C16H12N4O |
 |
Vitamin B1 Impurity 6 |
|
C12H17ClN4OS |
 |
5,5'-((tert-butylazanediyl)bis(1-hydroxyethane-2,1-diyl))bis(benzene- 1,3-diol) |
|
C20H27NO6 |
 |
2,2'-difluoro-3,3'-dimethoxy-1,1'-biphenyl |
2316733-82-9 |
C14H12F2O2 |
 |
nicergoline impurity N |
|
|
 |
Clopidogrel Impurity 50 |
|
C15H14ClNO2S |
 |
PraMipexole IMpurity Z1/Z2 |
|
|
 |
trans-Ibuprofen Impurity G |
|
C13H18O2 |
 |
Vonoprazan Impurity 15 |
|
|
 |
Erlotinib Impurity 22 |
|
|
 |
Teneligliptin Impurity 1 |
|
|
 |
Erlotinib Hydrochloride iMpurity 51 |
|
|
![(S)-10-(1-aminocyclopropyl)-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid formic acid](/CAS/20200401/GIF/CB65441219.gif) |
(S)-10-(1-aminocyclopropyl)-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid formic acid |
|
C17H18N2O6 |
 |
1H-Imidazole-1-ethanol, α-(chloromethyl)-5-nitro- |
116989-52-7 |
C6H8ClN3O3 |
 |
4-Pyridinemethanol, 3-hydroxy-2,5-dimethyl-, hydrochloride (1:1) |
875-26-3 |
C8H11NO2.ClH |
 |
5α-アンドロスタ-3-エン-17-オン |
14935-81-0 |
C19H28O |
 |
Landiolol impurity X |
|
|
 |
2-((4-(3-aminopiperidin-1-yl) |
|
|
 |
Rosuvastatin Impurity 111 |
|
|
 |
Metoprolol IMpurity V |
|
C15H25NO3 |
 |
Teneligliptin Impurity 12 |
|
|
 |
Nicergoline EP Impurity E |
|
|
![Hexanoic acid, 3-[(hydroxyamino)methyl]-5-methyl-, (3S)-](/CAS/20200401/GIF/2349671-57-2.gif) |
Hexanoic acid, 3-[(hydroxyamino)methyl]-5-methyl-, (3S)- |
2349671-57-2 |
C8H17NO3 |
![α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4,6-tetraacetate](/CAS/20211123/GIF/714269-58-6.gif) |
α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4,6-tetraacetate |
714269-58-6 |
C30H35ClO11 |
 |
Caspofungin Impurity H |
|
|
![(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine hydrochloride](/CAS/20200401/GIF/127017-41-8.gif) |
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine hydrochloride |
127017-41-8 |
C21H26ClNO4 |
 |
Ezetimibe Impurity 76 |
1185883-46-8 |
C39H44F2N2O5Si |
![Cefmetazole impurity 9/(6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-3-(hydroxymethyl)-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid](/CAS/20210305/GIF/70953-19-4.gif) |
Cefmetazole impurity 9/(6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-3-(hydroxymethyl)-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid |
70953-19-4 |
C13H15N3O6S2 |
 |
((cis)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate |
|
C20H24FNO3S |
 |
Elagolix Sodium impurity1 |
|
|
 |
Ibrutinib Impurity 37 |
330793-49-2 |
C10H13IN6 |
![(S)-((6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)amino)methanol](/CAS/20200401/GIF/CB65519826.gif) |
(S)-((6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)amino)methanol |
|
C11H19N3OS |
 |
(trans)-4-((6-amino-2,3-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
ERYTHROMYCIN IMPURITY N |
|
|
 |
Fesoterodine Impurity 12 |
|
|
 |
Dexamethasone EP impurities D |
|
|
 |
Palbociclib impurity LMAP |
|
|
 |
(3R,3'R)-3,3'-((((S)-1-amino-1-oxobutan-2-yl)azanediyl)bis(methylene))dihexanoic acid |
|
C18H34N2O5 |
 |
Acetaminophen EP Impurity L |
|
C8H9NO2 |
 |
(R)-4-(2-(benzyl(methyl)amino)-1-hydroxyethyl)benzene-1,2-diol |
317351-40-9 |
C16H19NO3 |
 |
N,N'-Bis(4-hydroxyphenyl)hydrazine |
158905-63-6 |
C12H12N2O2 |
 |
Droxidopa Impurity M |
|
|
 |
Aripiprazole peroxide degradation Impurity (MW:464Da) |
|
|
 |
Zileuton Impurity (MW = 279.31 Da) |
|
|
 |
Rivaroxaban Impurity 81 |
|
|
 |
Gadobutrol Impurity 21 |
|
|
 |
Flucloxacillin sodium EP Impurity E |
|
|
 |
Pyrazole |
|
|
 |
Cephalomannine (Paclitaxel Impurity I) |
|
|
 |
METOPROLOL IMPURITY D |
|
C15H25NO3 |
 |
NITRENDIPINE IMPURITY A |
|
|
 |
TAMSULOSIN IMPURITY D |
|
C20H28N2O5S |
 |
Macitentan Hydroxy amine Impurity |
2211059-05-9 |
C12H12BrN3O2 |
 |
1,3-diethyl-1,3-dimethylurea |
31468-19-6 |
C7H16N2O |
 |
Dapoxetine impurity 62 |
|
|
 |
Dapoxetine impurity 56 |
|
|
![N-[4-[[(2,4-ジアミノプテリジン-6-イル)メチル]メチルアミノ]ベンゾイル]-D-グルタミン酸](/CAS/GIF/51865-79-3.gif) |
N-[4-[[(2,4-ジアミノプテリジン-6-イル)メチル]メチルアミノ]ベンゾイル]-D-グルタミン酸 |
51865-79-3 |
C20H22N8O5 |
 |
Bimatoprost Impurity 11 |
|
|
 |
Bimatoprost Impurity 9 |
|
|
 |
Dolutegravir Impurity 18 |
|
|
 |
PeraMpanel |
380918-53-6 |
C23H15N3O |
 |
Lenvatinib Impurity 33 |
|
|
 |
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |